ATPS-51ESTABLISHING THE ROLE OF ARGININE DEPRIVATION WITH THE RECOMBINANT HUMAN ARGINASE PEG-BCT-100 IN THE TREATMENT OF ADULT GLIOMASJan 1, 2015·Herbert Loong,CT Choy,HT Cheong,Y Li,U KP,Aden Chan,CH Wong· 0 min read CiteLast updated on Jan 1, 2015 ← Low expressions of ASS1 and OTC in glioblastoma suggest the potential clinical use of recombinant human arginase (rhArg) Jan 1, 2016Preclinical evaluation of the recombinant human arginase PEG-BCT-100 leading to arginine deprivation in sarcomas Jan 1, 2015 →